2021 Shared Learning Meetings Kickoff Meeting – February 15, 2021

Document Type



Media is loading

Publication Date



On February 15, 2021 the American Diabetes Association (ADA) launched its inaugural Know Diabetes by Heart/Diabetes INSIDE® Shared Learning session to collaborating healthcare systems partners. In this kick-off presentation Greg Liptak and Dr. Robert Gabbay of the ADA provide welcoming remarks and stress the importance of getting the collaborative healthcare systems together to learn from and work with each other to combat the diabetes epidemic. Dr Furman will then present population level data from two of the collaborative healthcare system showcasing trends and gaps in diabetes and cardiovascular disease management in Greater Philadelphia.


Roy E. Furman, MD, PhD
Co-founder and Principal
Care Quality Action, LLC

Dr. Furman is a partner at Care Quality Action, LLC, a consultancy for quantifiable health care quality improvement, coaching, training, communications, and analysis services. He brings unique experience as a physician, scientist, entrepreneur, educator, executive, data analyst, and software developer in population health management, neurology, cardiology, endocrinology, oncology, biophysics, biochemistry, physiology, neuroscience, and engineering.

Dr. Furman was previously the medical director for the American Diabetes Association’s (ADA) quality improvement program, Diabetes INSIDE®, which he co-developed and led health care systems across the country to achieve quantifiable improvements in evidence-based clinical outcomes for patient populations with diabetes and cardiovascular diseases.

Prior to the ADA’s purchase of his company, Dr. Furman was the Medical Director, Chief Information Officer, and co-founder of Intelligent Medical Decisions, Inc. (iMD), a nationally-recognized company specializing in healthcare education and quality improvement. At iMD, Dr. Furman’s responsibilities included business and strategic planning, program medical content, quality improvement planning, education, and coaching, web development, publications, and statistical data analysis.

Dr. Furman was also the Director of Research and Development and co-founder of Scientific Software Tools, Inc. (SST), an award-winning custom software development company that has developed over 70 commercial products for international companies in the semiconductor, telecommunications, test and measurement, industrial process control, agriculture, hospitality, scientific research, pharmaceutical, medical, and life science industries.

Dr. Furman is a board-certified neurologist who was a faculty member of the Neurology Department at the University of Pennsylvania School of Medicine prior to starting his companies. At Penn, Dr. Furman combined clinical practice and clinical neurophysiology in neuromuscular disorders with biophysical research in the reconstitution of single ion channels in artificial membranes from muscle tissue and photoreceptors as well as research in artificial neural networks. He has research published in biophysics, biochemistry, physiology, neurology, oncology, cardiology, endocrinology, and engineering journals.

Dr. Furman received his SB from the Department of Earth, Atmospheric and Planetary Sciences of the Massachusetts Institute of Technology. He received his MD and PhD in Molecular Biology from the University of Pennsylvania. He did his residency in Neurology at Pennsylvania Hospital before becoming a Neurology Fellow at the University of Pennsylvania prior to joining Penn’s faculty.

Robert A. Gabbay, MD, PhD
Chief Scientific and Medical Officer
American Diabetes Association

Robert A. Gabbay, MD, PhD is Chief Scientific and Medical Officer of the American Diabetes Association and Associate Professor at Harvard Medical School and recently transition from his role as Chief Medical Office at the Joslin Diabetes Center. His research focuses on innovative models of diabetes care to improve to enhance diabetes outcomes and improve the lives of people with diabetes. To meet these goals, he has traversed many arenas including an initial career as a basic scientist researcher to development of better patient communication tools, creating the first broad scale diabetes registry, designing and implementing a care management training program, leading one of the largest primary care transformation efforts in the US around the Patient Centered Medical Home, involving over 150 primary care practices, and defining the medical neighborhood and the role of centers of excellence in diabetes and envisioning the digital health as the latest member of the diabetes team. Along with an extensive peer reviewed publication record, his views have appeared in popular press such as the New York Times, CNN, the Washington Post, People, Oprah, and National Public Radio.


Gregory S. Liptak
Vice President, Quality Improvement Services
American Diabetes Association

Prior to joining the American Diabetes Association (ADA), Greg Liptak was the President and co-founder of Intelligent Medical Decisions, Inc. (iMD), a company focused on improving healthcare quality. Mr. Liptak provided iMD with leadership experience developed over a focused career in healthcare spanning science, education, information technology and entrepreneurship. With over a decade of experience building public-private partnerships across the healthcare ecosystem, Mr. Liptak helped grow iMD into a leading provider of clinical quality improvement services.

Presentation: 50:15



This document is currently not available here.